227 related articles for article (PubMed ID: 15322236)
1. Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2.
Sasaki M; Suzuki H; Aoki J; Ito K; Meier PJ; Sugiyama Y
Mol Pharmacol; 2004 Sep; 66(3):450-9. PubMed ID: 15322236
[TBL] [Abstract][Full Text] [Related]
2. Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2).
Sasaki M; Suzuki H; Ito K; Abe T; Sugiyama Y
J Biol Chem; 2002 Feb; 277(8):6497-503. PubMed ID: 11748225
[TBL] [Abstract][Full Text] [Related]
3. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
[TBL] [Abstract][Full Text] [Related]
5. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2.
Cui Y; König J; Keppler D
Mol Pharmacol; 2001 Nov; 60(5):934-43. PubMed ID: 11641421
[TBL] [Abstract][Full Text] [Related]
6. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
7. Vectorial transport of enalapril by Oatp1a1/Mrp2 and OATP1B1 and OATP1B3/MRP2 in rat and human livers.
Liu L; Cui Y; Chung AY; Shitara Y; Sugiyama Y; Keppler D; Pang KS
J Pharmacol Exp Ther; 2006 Jul; 318(1):395-402. PubMed ID: 16627748
[TBL] [Abstract][Full Text] [Related]
8. Vectorial transport of the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic anion transporter OATP1B3 (OATP8) and the export pump ABCC2.
Letschert K; Komatsu M; Hummel-Eisenbeiss J; Keppler D
J Pharmacol Exp Ther; 2005 May; 313(2):549-56. PubMed ID: 15665139
[TBL] [Abstract][Full Text] [Related]
9. Transfecting the multidrug resistance protein 2 gene improves transcellular organic anion transport.
Itani T; Kobayashi Y; Kuroda M; Ma N; Mifuji R; Urawa N; Tanaka Y; Kaito M; Adachi Y
Int J Mol Med; 2005 Nov; 16(5):821-5. PubMed ID: 16211250
[TBL] [Abstract][Full Text] [Related]
10. OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human.
Sun P; Wang C; Liu Q; Meng Q; Zhang A; Huo X; Sun H; Liu K
Pharmacol Rep; 2014 Apr; 66(2):311-9. PubMed ID: 24911086
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.
Cui Y; König J; Buchholz JK; Spring H; Leier I; Keppler D
Mol Pharmacol; 1999 May; 55(5):929-37. PubMed ID: 10220572
[TBL] [Abstract][Full Text] [Related]
12. Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver.
Hagenbuch N; Reichel C; Stieger B; Cattori V; Fattinger KE; Landmann L; Meier PJ; Kullak-Ublick GA
J Hepatol; 2001 Jun; 34(6):881-7. PubMed ID: 11451172
[TBL] [Abstract][Full Text] [Related]
13. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein.
de Waart DR; Häusler S; Vlaming ML; Kunne C; Hänggi E; Gruss HJ; Oude Elferink RP; Stieger B
J Pharmacol Exp Ther; 2010 Jul; 334(1):78-86. PubMed ID: 20388726
[TBL] [Abstract][Full Text] [Related]
14. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
Hirouchi M; Kusuhara H; Onuki R; Ogilvie BW; Parkinson A; Sugiyama Y
Drug Metab Dispos; 2009 Oct; 37(10):2103-11. PubMed ID: 19628752
[TBL] [Abstract][Full Text] [Related]
15. Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells.
Kopplow K; Letschert K; König J; Walter B; Keppler D
Mol Pharmacol; 2005 Oct; 68(4):1031-8. PubMed ID: 16046661
[TBL] [Abstract][Full Text] [Related]
16. Solute Carrier Family of the Organic Anion-Transporting Polypeptides 1A2- Madin-Darby Canine Kidney II: A Promising In Vitro System to Understand the Role of Organic Anion-Transporting Polypeptide 1A2 in Blood-Brain Barrier Drug Penetration.
Liu H; Yu N; Lu S; Ito S; Zhang X; Prasad B; He E; Lu X; Li Y; Wang F; Xu H; An G; Unadkat JD; Kusuhara H; Sugiyama Y; Sahi J
Drug Metab Dispos; 2015 Jul; 43(7):1008-18. PubMed ID: 25908246
[TBL] [Abstract][Full Text] [Related]
17. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
18. Data-based mathematical modeling of vectorial transport across double-transfected polarized cells.
Bartholomé K; Rius M; Letschert K; Keller D; Timmer J; Keppler D
Drug Metab Dispos; 2007 Sep; 35(9):1476-81. PubMed ID: 17548463
[TBL] [Abstract][Full Text] [Related]
19. Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154.
Takada T; Weiss HM; Kretz O; Gross G; Sugiyama Y
Drug Metab Dispos; 2004 Nov; 32(11):1272-8. PubMed ID: 15280219
[TBL] [Abstract][Full Text] [Related]
20. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin.
Hirano M; Maeda K; Matsushima S; Nozaki Y; Kusuhara H; Sugiyama Y
Mol Pharmacol; 2005 Sep; 68(3):800-7. PubMed ID: 15955871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
